Endocarditis
John M. Embil
Sold by BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
AbeBooks Seller since January 11, 2012
New - Hardcover
Condition: New
Ships from Germany to U.S.A.
Quantity: 2 available
Add to basketSold by BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
AbeBooks Seller since January 11, 2012
Condition: New
Quantity: 2 available
Add to basketThis item is printed on demand - it takes 3-4 days longer - Neuware -This new addition will provide an update on the current prophylaxis guidelines, the new diagnostic approach in the detection of the disease, the proposed schemas to predict prognosis, and the new treatment strategies to improve the outcome of patients afflicted with this serious condition.Endocarditis is a serious disease with ahigh rate of morbidity and mortality.The in-hospital mortality remains at 10-20%. The poor outcome ofpatients with this condition is due in large part to the delay in making thediagnosis which frequently can be elusive.As a result of its wide spectrum of manifestations, endocarditis canmimic many different conditions ranging from stroke to renal failure. In order to minimize the delay in diagnosis,clinicians need to always be mindful of the possibility that endocarditis maybe the cause of the symptoms. There have been ongoing efforts in thedevelopment of molecular probes and new imaging techniques to improve ourability to identify the disease early and reliably. New treatment strategies have been studiedwith the aim to prevent complications and to improve survival.Thestructure of the previous edition is preserved.The book is divided into three sections with the first section coveringthe historical perspective and basic principles, the second section dealingwith the diagnosis and management approaches and the last section on specificclinical situations that pose management dilemmas. All the chapters will be updated to include newinformation from the recent studies. Inparticular, the approach to the use of antibiotic prophylaxis will beextensively revised to present and discuss the implications of the currentguidelines from different national societies including the American HeartAssociation and the British Society for Antimicrobial Chemotherapy.This update is timely and should be ofinterest to all clinicians involved in the care of patients with this seriousdisease. This new edition will be a good resource forinternists, infectious disease specialists, cardiologists and cardiac surgeonsalike . 424 pp. Englisch.
Seller Inventory # 9783319277820
This new addition will provide an update on the current prophylaxis guidelines, the new diagnostic approach in the detection of the disease, the proposed schemas to predict prognosis, and the new treatment strategies to improve the outcome of patients afflicted with this serious condition.
Endocarditis is a serious disease with a high rate of morbidity and mortality. The in-hospital mortality remains at 10-20%. The poor outcome of patients with this condition is due in large part to the delay in making the diagnosis which frequently can be elusive. As a result of its wide spectrum of manifestations, endocarditis can mimic many different conditions ranging from stroke to renal failure. In order to minimize the delay in diagnosis, clinicians need to always be mindful of the possibility that endocarditis may be the cause of the symptoms. There have been ongoing efforts in the development of molecular probes and new imaging techniques to improve our ability to identify the disease early and reliably. New treatment strategies have been studied with the aim to prevent complications and to improve survival.
The structure of the previous edition is preserved. The book is divided into three sections with the first section covering the historical perspective and basic principles, the second section dealing with the diagnosis and management approaches and the last section on specific clinical situations that pose management dilemmas. All the chapters will be updated to include new information from the recent studies. In particular, the approach to the use of antibiotic prophylaxis will be extensively revised to present and discuss the implications of the current guidelines from different national societies including the American Heart Association and the British Society for Antimicrobial Chemotherapy.
This update is timely and should be of interest to all clinicians involved in the care of patients with this serious disease. This new edition will be a good resource for internists, infectious disease specialists, cardiologists and cardiac surgeons alike .
"About this title" may belong to another edition of this title.
Allgemeine Geschäftsbedingungen mit Kundeninformationen
Inhaltsverzeichnis
Geltungsbereich
Vertragsschluss
Widerrufsrecht
Preise und Zahlungsbedingungen
Liefer- und Versandbedingungen
Eigentumsvorbehalt
Mängelhaftung
Anwendbares Recht
Gerichtsstand
Alternative Streitbeilegung
Der Versand ins Ausland findet IMMER mit DHL statt. Auch nach Österreich verschicken wir nur mit DHL! Daher Standardversand == Luftpost!
| Order quantity | 5 to 15 business days | 5 to 15 business days |
|---|---|---|
| First item | US$ 26.36 | US$ 26.36 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.